Author(s): Jordana Joy
Key Takeaways
- LUMIFY Preservative Free eye drops are statistically non-inferior to LUMIFY in reducing ocular redness, with similar efficacy and safety profiles.
- The study involved 380 participants, showing high compliance rates and a low incidence of side effects for both formulations.
- LUMIFY Preservative Free is a viable option for patients with sensitivities to preservatives, despite a slightly higher incidence of rebound redness.
- Future research may focus on longer-term outcomes and additional assessments beyond the initial treatment period.
Recent results from a phase 3 study assessing LUMIFY Preservative Free redness reliever eye drops (preservative-free brimonidine tartrate ophthalmic solution 0.025%, Bausch + Lomb) in comparison to LUMIFY redness reliever eye drops demonstrated that the preservative-free drops are statistically non-inferior to LUMIFY in reducing ocular redness in adults. The results from the randomized, active-controlled, multicenter study were published in Ophthalmology and Therapy 1,2
The primary objective of the study was to demonstrate that LUMIFY Preservative Free is non-inferior to LUMIFY in reducing ocular redness. The primary efficacy end point was an investigator-assessed ocular redness score 8 timepoints from 5-minutes to 240-minutes after drop administration on day 1. Finally, the secondary objective was to compare the safety of both drops.1
“Since launching in 2018, LUMIFY has been the No. 1 doctor-recommended redness reliever brand, known for delivering noticeable results in one minute and lasting up to eight hours,”1 said John Ferris, president of Consumer at Bausch + Lomb, in a news release from the company. “This study demonstrates that our new LUMIFY Preservative Free eye drops reduce redness quickly and are just as safe and effective as the original LUMIFY, providing a needed option for patients with eye sensitivities.”
Read more: https://rb.gy/yi5ah0
Source: Ophthalmology Times